Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 5, 1997, Pages 571-574

  Myles, Paul S ^a   Leong, Choy K ^a   Currey, Judy ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Nitric oxide; Systemic vascular resistance

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTICLE; ASSISTED VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; FEMALE; HEART HEMODYNAMICS; HEART SURGERY; HUMAN; INOTROPISM; INTENSIVE CARE; MALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SYSTEMIC VASCULAR RESISTANCE;

EID: 0030761513     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90006-9     Document Type: Article

References (30)

1. Myles PS, Olenikov I, Bujor MA, Davis BB: ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass: A case-control study. Med J Aust 158:675-677, 1993
2. Myles PS, Buckland MR, Cannon GB, et al: The association between gastric mucosal pH, endotoxemia and low systemic vascular resistance following cardiopulmonary bypass. J Cardiothorac Vasc Anesth 10:195-200, 1996
3. Suffradeni AF, Fromm RE. Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280-287, 1989
4. Evans T, Carpenter A, Kinderman H, Cohen J: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77-81, 1993
5. Nilsson L, Kulander L, Nystrom SO, Eriksson O: Endotoxins in cardiopulmonary bypass. J Thorac Cardjovasc Surg 100:777-780, 1990
6. Anderson LW, Landow L, Baek L, et al: Association between intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 21:210-217, 1993
7. Winlaw DS, Smythe GA, Keogh AM, et al: Increased nitric oxide production in heart failure. Lancet 344:373-374, 1994
8. Ruvolo G, Greco E, Speziale G, et al: Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg 57:1053-1058, 1994
9. Higgins TL, Estafanous FG, Loop FD, et al: Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: A clinical severity score. JAMA 267:2344-2348, 1992
10. Smythe GA, Drew CM, Brown D, et al: Clinical estimation of nitric oxide production using rapid, definitive GC/MS-SIM analysis of urine or plasma nitrate. Clin Biochem Rev 15:127, 1994
11. Lubin JH, Mitchell HG, Ershow AG: Sample size and power for case-control studies when exposures are continuous. Stat Med 7:363-376, 1988
12. Clinical Trials Design Program [computer program]. Version 1.0. Cambridge, MA, Biosoft, 1990
13. Mackenzie IMJ, Young JD, Garrard CS: Serum nitrates as markers of postoperative morbidity. Lancet 344:410, 1994
14. Booth BP, Brien JF, Marks GS, et al: The effects of hypothermic and normothermic cardiopulmonary bypass on glyceryl trinitrate activity. Anesth Analg 78:848-856, 1994
15. l5N-labelled nitrate in humans: Effect of diet supplementation with ascorbic acid. Cancer Res 43:1921-1925, 1983
16. Moncada S: The L-arginine:nitric oxide pathway. Acta Physiol Scand 145:201-207, 1992
17. Tibballs J: The role of nitric oxide (formerly endothelium-derived relaxing factor - EDRF) in vasodilation and vasodilator therapy. Anaesth Intens Care 21:759-773, 1993
18. Anggard E: Nitric oxide: Mediator, murderer, and medicine. Lancet 343:1199-1205, 1994
19. Gómez-Jiménez J, Salgado A, Mourelle M, et al: L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253-258, 1995
20. 2--independant nitric oxide synthase activity in human lung after cardiopulmonary bypass. Thorax 50:403-404, 1995
21. Hibbs JR, Westenfelder C, Taintor R, et al: Evidence for cytokine-inducible nitric oxide from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867-877, 1992
22. Tsujino M, Hirata Y, Imai T, et al: Induction of nitric oxide synthase gene by interleukin-1β in cultured rat cardiocytes. Circulation 90:375-383, 1994
23. Thaker U, Geary V, Chalmers P, Sheikh F: Low systemic vascular resistance during cardiac surgery: Case reports, brief review, and management with angiotensin II. J Cardiothorac Vase Anesth 4:360-363, 1990
24. Kawamura T, Wakusawa R, Okada K, Inada S: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 40:1016-1021, 1993
25. Romanelli VA, Howie MB, Myerowitz PD, et al: Intraoperative and postoperative effects of vancomycin administration in cardiac surgery patients: A prospective, double-blind, randomized trial. Crit Care Med 21:1124-1131, 1993
26. Levy JH, Kettlekamp N, Goertz P, et al: Histamine release by vancomycin: A mechanism for hypotension in man. Anesthesiology 67:122-125, 1987
27. van Dissel JT, Groeneveld PHP, Maes B, et al: Nitric oxide: A predictor of morbidity in postoperative patients. Lancet 343:1579-1580, 1994
28. Mackenzie IMJ, Young JD, Garrad CS: Serum nitrates as markers of postoperative morbidity. Lancet 344:410, 1994
29. Preiser J-C, Lejeune P, Roman A, et al: Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23:259-414, 1995
30. Sahai J, Healy DP, Garris R, et al: Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome. J Infect Dis 160:876-881, 1989